Involvement of Annexin V in Antiproliferative Effects of Gonadotropin-Releasing Hormone Agonists on Human Endometrial Cancer Cell Line

By Shibata S.   Sato H.   Ota H.   Karube A.   Takahashi O.   Tanaka T.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 217-221

Elsevier

Access to resources Recommend Favorite

Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer

By Lauro Luigi   Vici Patrizia   Medico Pietro   Laudadio Lucio   Tomao Silverio   Giannarelli Diana   Pizzuti Laura   Sergi Domenico   Barba Maddalena   Maugeri-Saccà Marcello  

Breast Cancer Research and Treatment, Vol. 141, Iss. 1, 2013-08 ,pp. : 119-123

Springer Publishing Company

Access to resources Recommend Favorite

A novel bispidinone analog induces Sphase cell cycle arrest and apoptosis in HeLa human cervical carcinoma cells

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1526-1532

Spandidos Publications

Access to resources Recommend Favorite

Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric Data

By Agorastos T.   Bontis J.   Vakiani A.   Vavilis D.   Constantinidis T.  

Gynecologic Oncology, Vol. 65, Iss. 1, 1997-04 ,pp. : 102-114

Elsevier

Access to resources Recommend Favorite

Atypical Endometrial Hyperplasia Treatment with Progestogens and Gonadotropin-Releasing Hormone Analogues: Long-Term Follow-up

By Perez-Medina T.   Bajo J.   Folgueira G.   Haya J.   Ortega P.  

Gynecologic Oncology, Vol. 73, Iss. 2, 1999-05 ,pp. : 299-304

Elsevier

Access to resources Recommend Favorite